These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21094455)

  • 41. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system.
    Choi JY; Kim MJ; Chung YE; Kim JY; Jones AC; de Becker J; van Cauteren M
    Radiographics; 2008; 28(4):e30. PubMed ID: 18426969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.
    Kuhl CK; Träber F; Schild HH
    Radiology; 2008 Mar; 246(3):675-96. PubMed ID: 18309012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging of biliary tumors.
    Matos C; Serrao E; Bali MA
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):477-96, x. PubMed ID: 21094451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3.0-T MR imaging of the abdomen: comparison with 1.5 T.
    Chang KJ; Kamel IR; Macura KJ; Bluemke DA
    Radiographics; 2008; 28(7):1983-98. PubMed ID: 19001653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gadolinium-phthalein complexone as a contrast agent for hepatobiliary MR imaging.
    Kawamura Y; Endo K; Koizumi M; Watanabe Y; Saga T; Konishi J; Horiuchi K; Yokoyama A
    J Comput Assist Tomogr; 1989; 13(1):67-70. PubMed ID: 2910950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology.
    Koh DM; Padhani AR
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):565-85, xii. PubMed ID: 21094456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents.
    Gupta RT; Brady CM; Lotz J; Boll DT; Merkle EM
    AJR Am J Roentgenol; 2010 Aug; 195(2):405-13. PubMed ID: 20651197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric high-field magnetic resonance imaging.
    Dahmoush HM; Vossough A; Roberts TP
    Neuroimaging Clin N Am; 2012 May; 22(2):297-313, xi. PubMed ID: 22548934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver MRI: From basic protocol to advanced techniques.
    Donato H; França M; Candelária I; Caseiro-Alves F
    Eur J Radiol; 2017 Aug; 93():30-39. PubMed ID: 28668428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI: how to perform a pediatric scan.
    Olsen ØE
    Acta Radiol; 2013 Nov; 54(9):991-7. PubMed ID: 23390159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in MR Imaging of the Biliary Tract.
    Welle CL; Miller FH; Yeh BM
    Magn Reson Imaging Clin N Am; 2020 Aug; 28(3):341-352. PubMed ID: 32624153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body MR imaging: fast, efficient, and comprehensive.
    Kim BS; Angthong W; Jeon YH; Semelka RC
    Radiol Clin North Am; 2014 Jul; 52(4):623-36. PubMed ID: 24889164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Formation and suppression technique for motion and flow artifacts on magnetic resonance imaging].
    Zhang Y; Cheng JL; Li HL; Wang J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Mar; 33(2):116-9. PubMed ID: 19565797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body MR imaging at 3.0 T: understanding the opportunities and challenges.
    Barth MM; Smith MP; Pedrosa I; Lenkinski RE; Rofsky NM
    Radiographics; 2007; 27(5):1445-62; discussion 1462-4. PubMed ID: 17848702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detailing magnetic field strength dependence and segmental artifact distribution of myocardial effective transverse relaxation rate at 1.5, 3.0, and 7.0 T.
    Meloni A; Hezel F; Positano V; Keilberg P; Pepe A; Lombardi M; Niendorf T
    Magn Reson Med; 2014 Jun; 71(6):2224-30. PubMed ID: 23813553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Head and neck high-field imaging: oncology applications.
    Bou-Assaly W; Srinivasan A; Mukherji SK
    Neuroimaging Clin N Am; 2012 May; 22(2):285-96, xi. PubMed ID: 22548933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatobiliary imaging.
    Liu PS; Abramson RG
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):xv-xvi. PubMed ID: 25086942
    [No Abstract]   [Full Text] [Related]  

  • 59. Pediatric hepatobiliary magnetic resonance imaging.
    Tran VT; Vasanawala S
    Radiol Clin North Am; 2013 Jul; 51(4):599-614. PubMed ID: 23830788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatobiliary imaging. Foreword.
    Mukherji SK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):xiii. PubMed ID: 25086941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.